Brinzolamide/Timolol Maleate

布林佐胺/马来酸噻吗洛尔

Report date: 2023/12/22 17:42:25

Base Information

Drug NameBrinzolamide/Timolol Maleate
Drug Alias Name马来酸噻吗洛尔/布林佐胺Timolol Maleate and BrinzolamideBrinzolamide - timolol maleate mixt布林佐胺噻吗洛尔Timolol Maleate/Brinzolamide +[10] 
ClassificationSmall molecules
Mechanisms of ActionCarbonic anhydrase II inhibitorsBeta adrenergic receptors antagonists
TargetsBeta adrenergic receptorsCarbonic anhydrase II
Therapy Area/IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Global Approved IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Approved Indications in ChinaGlaucoma, Open-AngleOcular Hypertension
Original Approved Country/TerritoryEU
Original Approved Date2008/11/25
Country/TerritoryUnited StatesEUMainland China +[4] 
CombinationsYes Timolol MaleateBrinzolamide
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAlcon
China Registration ClassN/A

Develop Information

Active CompaniesAlcon Laboratories (U.K.) LtdNovartis Pharma AgNovartis Europharm Ltd
Inactive CompaniesAlcon
Active IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeS01ED51
Related LinksKEGG